New directions for breast cancer therapeutic research.
作者信息
Friedman M A
机构信息
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.
出版信息
Hematol Oncol Clin North Am. 1994 Feb;8(1):113-9.
PMID:8150774
Abstract
For the past two decades, attempts to improve chemotherapy for patients with breast cancer have emphasized the use of currently available agents. Research by drug discovery programs of the National Cancer Institute has identified a number of clinically promising novel agents. Conceivably, within the next several years there could be a doubling of the chemotherapy armamentarium for breast cancer--more than 30 active cytotoxic agents.
摘要
相似文献
1
New directions for breast cancer therapeutic research.
Hematol Oncol Clin North Am. 1994 Feb;8(1):113-9.
2
New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.治疗转移性乳腺癌的新型细胞毒性药物和分子靶向疗法。
Forum (Genova). 2002;12(1):4-15.
3
[Current trends in pharmacotherapy of breast cancer].[乳腺癌药物治疗的当前趋势]
Orv Hetil. 2002 Apr 7;143(14):725-30.
4
Carboplatin in combination therapy for metastatic breast cancer.卡铂在转移性乳腺癌联合治疗中的应用
Oncologist. 2004;9(5):518-27. doi: 10.1634/theoncologist.9-5-518.
5
6
Metastatic breast cancer: the role of chemotherapy.转移性乳腺癌：化疗的作用
Semin Oncol. 1999 Feb;26(1 Suppl 2):6-10.
7
[Effective treatment strategy in elderly breast cancer patients].[老年乳腺癌患者的有效治疗策略]
Orv Hetil. 2005 Jan 2;146(1):15-21.
8
Implications of the new biology for therapy in breast cancer.新生物学对乳腺癌治疗的启示。
Semin Oncol. 1996 Feb;23(1 Suppl 2):76-81.
9
The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.造血生长因子在支持乳腺癌患者进行细胞毒性化疗中的应用。
Hematol Oncol Clin North Am. 1994 Feb;8(1):233-49.
10
Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy.老年转移性乳腺癌的细胞毒性治疗：安全性、药代动力学及疗效综述
Eur J Cancer. 2007 Jul;43(10):1514-28. doi: 10.1016/j.ejca.2007.03.017. Epub 2007 May 4.
引用本文的文献
1
Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.
Invest New Drugs. 1994;12(4):333-6. doi: 10.1007/BF00873050.
2
Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast.乳腺原发性导管癌中拓扑异构酶II-α表达的免疫组织化学研究。
J Clin Pathol. 1995 Feb;48(2):147-50. doi: 10.1136/jcp.48.2.147.
Zotero 插件